News

To better understand the ever evolving clinical trial landscape and continue to be the authority in innovation, Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, has released its global 2023 State of Clinical Trial Patient...

Leading UK contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has completed the build of its new development and GMP manufacturing headquarters in Nottingham, UK. Situated less than two miles from Upperton’s current HQ, the facility houses ten new...

Phastar, a global specialist biometrics contract research organization (CRO), has become a certified B Corporation®. It comes after a stringent 12-month review to ensure protocols and procedures reflect the company’s commitment to high environment, social, and governance (EGS) standards. Certified...

Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with traditional medicine. These therapies involve introducing, replacing, or deactivating genes in cells, either inside or...

A recent article published in the Journal of Membrane Science presents a new approach for implementing a robust single-pass tangential flow filtration (SP-TFF) operation in biomanufacturing. The authors introduce a process analytical technology (PAT)-based strategy that integrates and continuously...

Making the right contract development and manufacturing choice happens to be a pivotal decision for biopharmaceutical firms that happen to be embarking on projects pertaining to novel antibody development. With the sector’s rising demand when it comes to qualified multidisciplinary...

New recommendations from Imperial College London aim to boost competitiveness in the UK's biopharma and Medtech sectors. It assesses the value-added per capita in these sectors and provides insights into their needs, challenges, and opportunities. Technological solutions and policy...